{
  "MM_50ug_IMAC_Bravo_R3.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_50ug_IMAC_Bravo_R3"
    ],
    "Raw Data File": [
      "MM_50ug_IMAC_Bravo_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "50ug"
    ]
  },
  "MM1_R3.raw": {
    "Source Name": [
      "MM1"
    ],
    "Assay Name": [
      "MM1_MM1_R3"
    ],
    "Raw Data File": [
      "MM1_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM1"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_50ug_IMAC_Bravo_R1.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_50ug_IMAC_Bravo_R1"
    ],
    "Raw Data File": [
      "MM_50ug_IMAC_Bravo_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "50ug"
    ]
  },
  "MM_100ug_IMAC_Bravo_R3.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_100ug_IMAC_Bravo_R3"
    ],
    "Raw Data File": [
      "MM_100ug_IMAC_Bravo_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "100ug"
    ]
  },
  "F3_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F3_MM2"
    ],
    "Raw Data File": [
      "F3_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F3"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM3_R2.raw": {
    "Source Name": [
      "MM3"
    ],
    "Assay Name": [
      "MM3_MM3_R2"
    ],
    "Raw Data File": [
      "MM3_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM3"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_50ug_IMAC_Bravo_R2.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_50ug_IMAC_Bravo_R2"
    ],
    "Raw Data File": [
      "MM_50ug_IMAC_Bravo_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "50ug"
    ]
  },
  "FT_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_FT_MM2"
    ],
    "Raw Data File": [
      "FT_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "FT"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_200ug_IMAC_Bravo_R3.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_200ug_IMAC_Bravo_R3"
    ],
    "Raw Data File": [
      "MM_200ug_IMAC_Bravo_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "200ug"
    ]
  },
  "F6_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F6_MM2"
    ],
    "Raw Data File": [
      "F6_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F6"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_100ug_IMAC_Bravo_R2.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_100ug_IMAC_Bravo_R2"
    ],
    "Raw Data File": [
      "MM_100ug_IMAC_Bravo_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "100ug"
    ]
  },
  "MM_200ug_IMAC_Bravo_R2.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_200ug_IMAC_Bravo_R2"
    ],
    "Raw Data File": [
      "MM_200ug_IMAC_Bravo_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "200ug"
    ]
  },
  "MM_12ug_IMAC_Bravo_R3.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_12ug_IMAC_Bravo_R3"
    ],
    "Raw Data File": [
      "MM_12ug_IMAC_Bravo_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "12ug"
    ]
  },
  "MM2_R2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_MM2_R2"
    ],
    "Raw Data File": [
      "MM2_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_100ug_IMAC_Bravo_R1.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_100ug_IMAC_Bravo_R1"
    ],
    "Raw Data File": [
      "MM_100ug_IMAC_Bravo_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "100ug"
    ]
  },
  "MM_25ug_IMAC_Bravo_R1.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_25ug_IMAC_Bravo_R1"
    ],
    "Raw Data File": [
      "MM_25ug_IMAC_Bravo_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "25ug"
    ]
  },
  "F1_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F1_MM2"
    ],
    "Raw Data File": [
      "F1_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F1"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_12ug_IMAC_Bravo_R1.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_12ug_IMAC_Bravo_R1"
    ],
    "Raw Data File": [
      "MM_12ug_IMAC_Bravo_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "12ug"
    ]
  },
  "MM_25ug_IMAC_Bravo_R2.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_25ug_IMAC_Bravo_R2"
    ],
    "Raw Data File": [
      "MM_25ug_IMAC_Bravo_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "25ug"
    ]
  },
  "F2_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F2_MM2"
    ],
    "Raw Data File": [
      "F2_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F2"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "F4_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F4_MM2"
    ],
    "Raw Data File": [
      "F4_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F4"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_25ug_IMAC_Bravo_R3.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_25ug_IMAC_Bravo_R3"
    ],
    "Raw Data File": [
      "MM_25ug_IMAC_Bravo_R3.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R3"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "25ug"
    ]
  },
  "F5_MM2.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_F5_MM2"
    ],
    "Raw Data File": [
      "F5_MM2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[FractionIdentifier]": [
      "F5"
    ],
    "Comment[NumberOfFractions]": [
      "collection of seven fractions that included the flow-through."
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_200ug_IMAC_Bravo_R1.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_200ug_IMAC_Bravo_R1"
    ],
    "Raw Data File": [
      "MM_200ug_IMAC_Bravo_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "200ug"
    ]
  },
  "MM3_R1.raw": {
    "Source Name": [
      "MM3"
    ],
    "Assay Name": [
      "MM3_MM3_R1"
    ],
    "Raw Data File": [
      "MM3_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM3"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM1_R1.raw": {
    "Source Name": [
      "MM1"
    ],
    "Assay Name": [
      "MM1_MM1_R1"
    ],
    "Raw Data File": [
      "MM1_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM1"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM2_R1.raw": {
    "Source Name": [
      "MM2"
    ],
    "Assay Name": [
      "MM2_MM2_R1"
    ],
    "Raw Data File": [
      "MM2_R1.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[BiologicalReplicate]": [
      "MM2"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R1"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ]
  },
  "MM_12ug_IMAC_Bravo_R2.raw": {
    "Source Name": [
      "pooled sample"
    ],
    "Assay Name": [
      "pooled sample_MM_12ug_IMAC_Bravo_R2"
    ],
    "Raw Data File": [
      "MM_12ug_IMAC_Bravo_R2.raw"
    ],
    "Characteristics[MaterialType]": [
      "MM tumor tissues"
    ],
    "Characteristics[Specimen]": [
      "sectioned, fresh-frozen tissues from human MM lymph node metastases tissues (10 μm)"
    ],
    "Characteristics[OrganismPart]": [
      "lymph node metastases"
    ],
    "Characteristics[CleavageAgent]": [
      "Lys-C",
      "trypsin"
    ],
    "Characteristics[ReductionReagent]": [
      "10 mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "20 mM iodoacetamide"
    ],
    "Characteristics[PooledSample]": [
      "a pool of eight MM tumor lysates"
    ],
    "Characteristics[TechnicalReplicate]": [
      "R2"
    ],
    "Comment[EnrichmentMethod]": [
      "Automated Fe(III)-IMAC-based workflow"
    ],
    "Comment[Instrument]": [
      "Thermo Easy-nLC 1000 HPLC coupled on-line to a Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA)",
      "Ultimate 3000 HPLC coupled to a Q Exactive HF-X mass spectrometer (Thermo Scientific, San Jose, CA)"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent analysis (DDA)"
    ],
    "Comment[FragmentationMethod]": [
      "fragmentation in the HCD collision cell"
    ],
    "Comment[GradientTime]": [
      "using a 120 min ACN gradient in 0.1% formic acid"
    ],
    "Comment[FlowRateChromatogram]": [
      "flow rate of 300 nL/min"
    ],
    "Comment[MS2MassAnalyzer]": [
      "Orbitrap analyzer"
    ],
    "Comment[PrecursorMassTolerance]": [
      "10 ppm"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02 Da"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "A maximum of two missed cleavage sites were accepted."
    ],
    "FactorValue[Treatment]": [
      "12ug"
    ]
  }
}